» Articles » PMID: 19054404

Assessment of Seizure Susceptibility in Pilocarpine Epileptic and Nonepileptic Wistar Rats and of Seizure Reinduction with Pentylenetetrazole and Electroshock Models

Overview
Journal Epilepsia
Specialty Neurology
Date 2008 Dec 5
PMID 19054404
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Pentylenetetrazole (PTZ) and maximal electroshock (MES) models are often used to induce seizures in nonepileptic control animals or naive animals. Despite being widely used to screen antiepileptic drugs (AEDs), both models have so far failed to detect potentially useful AEDs for treating drug-resistant epilepsies. Here we investigated whether the acute induction of MES and PTZ seizures in epileptic rats might yield a distinct screening profile for AEDs.

Methods: Status epilepticus (SE) was induced in adult male Wistar rats by intraperitoneal pilocarpine injection (Pilo, 320 mg/kg, i.p.). One month later, controls or naive animals (Cont) that did not develop SE postpilocarpine (N-Epi) and pilocarpine-epileptic rats (Epi) received one of the following: phenobarbital (PB, 40 mg/kg), phenytoin (PHT, 50 mg/kg), or valproic acid (VPA, 400 mg/kg). Thirty min later the animals were challenged with either subcutaneous MES or PTZ (50 mg/kg, s.c.).

Results: VPA, PB, and PHT were able to prevent MES in all groups tested (Cont, N-Epi, and Epi groups), whereas for the PTZ model, only the Cont group (naive animals) had seizure control with the same AEDs. In addition, Epi and N-Epi groups when challenged with PTZ exhibited a higher incidence of severe seizures (scores IV-IX) and SE (p < 0.05, Fisher's exact test).

Conclusions: Our findings suggest that the induction of acute seizures with PTZ, but not with MES, in animals pretreated with pilocarpine (regardless of SE induction) might constitute an effective and valuable method to screen AEDs and to study mechanisms involved in pharmacoresistant temporal lobe epilepsy (TLE).

Citing Articles

Potential of to mitigate epileptogenesis and cognitive dysfunction on kainate-induced post- model.

Kandeda A, Foutse L, Lewale S, Dimo T IBRO Neurosci Rep. 2025; 18():57-65.

PMID: 39844945 PMC: 11750482. DOI: 10.1016/j.ibneur.2024.12.007.


Antiepileptic and anti-inflammatory effects of moldenke (Verbenaceae) in mice model of chronic temporal lobe epilepsy induced by pilocarpine.

Ngaibi J, Bigued , Kandeda A, Nguezeye Y, Wangbara T, Gaoudji L Heliyon. 2024; 10(20):e39483.

PMID: 39498072 PMC: 11533593. DOI: 10.1016/j.heliyon.2024.e39483.


Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments.

Loscher W, White H Cells. 2023; 12(9).

PMID: 37174633 PMC: 10177106. DOI: 10.3390/cells12091233.


Potential new roles for glycogen in epilepsy.

Dienel G, Gillinder L, McGonigal A, Borges K Epilepsia. 2022; 64(1):29-53.

PMID: 36117414 PMC: 10952408. DOI: 10.1111/epi.17412.


Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach.

Mensah J, Johnson K, Reilly C, Wilcox K, Rower J, Metcalf C Epilepsia. 2022; 63(11):2937-2948.

PMID: 36054499 PMC: 9669179. DOI: 10.1111/epi.17402.